Everest Re Group, Ltd.

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

21
Slightly Bearish -15

Wells Fargo sets USD 396.00 target for Everest Group stock

Analyst upgrade AI-generated analysis

Wells Fargo analyst firm set a USD 396.00 price target for Everest Group stock on October 12, maintaining a Hold rating. At the time of reporting on October 15, 2026, the stock was trading at EUR 339.70, placing the analyst target above the current market...

Bullish Signals

  • Wells Fargo set a $396 price target above current EUR 339.70 price.
  • Stock trades within its 52-week range of $302.44 to $401.07.

Bearish Signals

  • Q2 revenue missed expectations at $3.96B vs $4.02B consensus.
22
Bullish +65

Everest Medicines Secures Greater China Rights to Presbyopia Eye Drop LNZ100

AI-generated analysis

Everest Medicines Ltd. (HK:1952) has secured an exclusive license from Corxel Pharmaceuticals to develop, manufacture, and commercialize LNZ100, a once-daily prescription eye drop for presbyopia, across Greater China. The agreement includes an upfront payment, regulatory and sales milestones, and tiered royalties, aiming to expand Everest's...

Bullish Signals

  • Exclusive LNZ100 license secured for Greater China market.
  • Upfront payments and tiered royalties provide financial upside.
  • US approval reduces regulatory risk for Chinese entry.
  • China regulatory approval expected by 2027 timeline.
  • Targets large presbyopic population from mid-40s to mid-70s.
23
Somewhat Bearish -25

What Does Everest Group (EG) Lawsuit Mean For Reserve Transparency?

Class action Lawsuit AI-generated analysis

Everest Group (NYSE:EG) is facing a newly filed securities class action lawsuit alleging that executives made misleading disclosures regarding casualty risk exposure and the adequacy of loss reserves. Plaintiffs argue that long-standing issues with risk concentration and reserve sufficiency distorted the company's reported financial risk...

Bullish Signals

  • Lawsuit should not dominate investment view of Everest Group.
  • US insurer with $15.5B market value underwriting globally.

Bearish Signals

  • Securities class action alleges misleading casualty risk disclosure.
  • Plaintiffs claim distorted financial risk profile from reserves.
  • Lawsuit challenges conservative reserving narrative and understated exposure.
  • Reserve estimates may not align with actuarial central points.
24
Slightly Bullish +15

Everest Group (EG) Faces Reserve Lawsuit, Is The Stock Slightly Overvalued?

Class action Earnings report AI-generated analysis

Everest Group (NYSE:EG) is facing renewed scrutiny following a new securities class action lawsuit alleging the insurer understated casualty reserves and misrepresented risk exposure. Despite this legal backdrop, the company's share price has demonstrated resilience, posting a 1-month return of 12.54% and a year-to-date return...

Bullish Signals

  • Share price rose 12.54% in 1 month and 22.87% YTD.

Bearish Signals

  • Lawsuit accuses insurer of understating reserves and misrepresenting risk.
  • Analysts classify Everest Group as slightly overvalued at $408.47.
  • P/E of 8.2x below industry average raises hidden risk questions.
25
Somewhat Bullish +45

The Zacks Analyst Blog Highlights RenaissanceRe, Arch Capital, Everest

AI-generated analysis

Zacks Investment Research highlights Everest Group (EG) alongside RenaissanceRe and Arch Capital as well-positioned reinsurers to benefit from the growing alternative capital boom. The article notes that global alternative capital reached a record $144.5 billion in mid-2026, with significant growth in catastrophe bonds and sidecars,...

Bullish Signals

  • Mt. Logan AUM surged 89% to $3.4B by July 2026.
  • Annapurna Re sidecar deploys $600M over three years.
  • Analysts project 19.4% increase in 2026 bottom line.

Bearish Signals

  • Competition may pressure reinsurance pricing by 2027.
  • Zacks Rank #3 indicates analysts hold, not strong buy.